| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2074 | 2017 |
| Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland ES Björnsson, OM Bergmann, HK Björnsson, RB Kvaran, S Olafsson Gastroenterology 144 (7), 1419-1425. e3, 2013 | 952 | 2013 |
| Large-scale whole-genome sequencing of the Icelandic population DF Gudbjartsson, H Helgason, SA Gudjonsson, F Zink, A Oddson, ... Nature genetics 47 (5), 435-444, 2015 | 837 | 2015 |
| Complications of intracranial pressure monitoring in fulminant hepatic failure AT Blei, S Olafsson, S Webster, R Levy The Lancet 341 (8838), 157-158, 1993 | 332 | 1993 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 304 | 2022 |
| Ammonia‐induced brain edema and intracranial hypertension in rats after portacaval anastomosis AT Blei, S Olafsson, G Therrien, RF Butterworth Hepatology 19 (6), 1437-1444, 1994 | 282 | 1994 |
| Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe AD Marshall, EB Cunningham, S Nielsen, A Aghemo, H Alho, ... The lancet Gastroenterology & hepatology 3 (2), 125-133, 2018 | 165 | 2018 |
| Risk of drug-induced liver injury from tumor necrosis factor antagonists ES Björnsson, BI Gunnarsson, G Gröndal, JG Jonasson, R Einarsdottir, ... Clinical Gastroenterology and Hepatology 13 (3), 602-608, 2015 | 130 | 2015 |
| The present and future disease burden of hepatitis C virus infections with today's treatment paradigm–volume 3 A Sibley, KH Han, A Abourached, LA Lesmana, M Makara, W Jafri, ... Journal of viral hepatitis 22, 21-41, 2015 | 102 | 2015 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 3 V Liakina, S Hamid, J Tanaka, S Olafsson, AI Sharara, SM Alavian, ... Journal of viral hepatitis 22, 4-20, 2015 | 98 | 2015 |
| Treatment as Prevention for Hepatitis C (TraP Hep C)–a nationwide elimination programme in Iceland using direct‐acting antiviral agents S Ólafsson, T Tyrfingsson, V Rúnarsdóttir, OM Bergmann, I Hansdóttir, ... Journal of internal medicine 283 (5), 500-507, 2018 | 89 | 2018 |
| Genome-wide association meta-analysis yields 20 loci associated with gallstone disease E Ferkingstad, A Oddsson, S Gretarsdottir, S Benonisdottir, G Thorleifsson, ... Nature communications 9 (1), 5101, 2018 | 87 | 2018 |
| Acute liver failure P Rajaram, R Subramanian Seminars in Respiratory and Critical Care Medicine 39 (05), 513-522, 2018 | 80* | 2018 |
| Multiomics study of nonalcoholic fatty liver disease G Sveinbjornsson, MO Ulfarsson, RB Thorolfsdottir, BA Jonsson, ... Nature genetics 54 (11), 1652-1663, 2022 | 73 | 2022 |
| Drug-induced autoimmune hepatitis: response to corticosteroids and lack of relapse after cessation of steroids ES Björnsson, O Bergmann, JG Jonasson, G Grondal, B Gudbjornsson, ... Clin Gastroenterol Hepatol 15 (10), 1635-6, 2017 | 70 | 2017 |
| Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes SA Gunnarsdottir, R Olsson, S Olafsson, N Cariglia, J Westin, ... Scandinavian journal of gastroenterology 44 (8), 984-993, 2009 | 65 | 2009 |
| Modelling the elimination of hepatitis C as a public health threat in Iceland: a goal attainable by 2020 N Scott, S Ólafsson, M Gottfreðsson, T Tyrfingsson, V Rúnarsdóttir, ... Journal of hepatology 68 (5), 932-939, 2018 | 64 | 2018 |
| Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives S Olafsson, H Gudjonsson, C Selmi, K Amano, P Invernizzi, M Podda, ... Official journal of the American College of Gastroenterology| ACG 99 (11 …, 2004 | 62 | 2004 |
| Innovative strategies for the elimination of viral hepatitis at a national level: a country case series SE Schröeder, A Pedrana, N Scott, D Wilson, C Kuschel, L Aufegger, ... Liver International 39 (10), 1818-1836, 2019 | 59 | 2019 |
| Strategies to manage hepatitis C virus infection disease burden–volume 3 FZ Alfaleh, N Nugrahini, M Matičič, I Tolmane, M Alzaabi, B Hajarizadeh, ... Journal of viral hepatitis 22, 42-65, 2015 | 54 | 2015 |
